Pharmaceutical Technology Editors

To help meet the needs of the fast-growing, global biopharmaceuticals industry, Pall Corporation has launched five innovative technologies aimed at increasing drug-manufacturing efficiency through customization and disposability. The Mustang XT5000 capsule is the company's novel chromatography technology for efficient capture of large molecules, especially used to develop DNA and virus-based drugs. Expanding its portfolio of technologies for disposable processing, Pall offers both the customizable Tangential Flow Filtration system, which incorporates single-use components for downstream processing applications, and the Kleenpak Connector — a new single-use device, which enables aseptic connections to be made instantly.

Colorcon has opened three specially equipped design centres devoted to tablet brand imaging. Located in West Point (PA, USA), Dartford (UK) and Goa (India), the facilities form an integral part of the brand enhancement system for tablets — a unique service supporting new product development and brand management of an existing product. Each design facility is equipped for collaboration between Colorcon experts and a client's own project team.

Aptuit To Purchase Quintiles

Able Labs Files for Chapter 11

Xanodyne Acquires aaiPharma Assets

Able Interim Chief Resigns Amid Drug Recall

Able Laboratories, Inc. (Cranbury, NJ, www.ablelabs.com) announced in late May that it would halt all production and recall all available product because of problematic testing procedures discovered during an internal investigation. The company manufactures mostly generic prescription drugs, including drugs containing acetaminophen.

Schering AG To Cut Plants and Staff

Wyeth and Purdue Announce Restructuring Plans

Pharmaceutical science and technology news.

Regulation: FDA Steps Up Action Against Counterfeit Drugs, Warns US Consumers Against Fake Medicine from Mexico

Once considered mainly an afterthought in a company's lifecycle-management strategy, controlled-release dosage forms are now positioned at the forefront of many formulation strategies. In contrast to drug discovery, formulation work focuses not only on the intricacies of the active pharmaceutical ingredient (API), but also on fine-tuning the excipients, the release profile, and the delivery mechanism to provide optimal therapeutic benefit. Because of their wide range of applications and functionalities, especially in controlled-release therapies, polymers are among the most widely used excipients.

Purdue?s RFID Pedigree Program Enters Pilot Phase

Compounding Pharmacies' Lawsuit Against FDA Will Continue

Cytogen and Dowpharm to Develop Targeted Anticancer Product

Bedford Recall

GSK and FDA Agree on Consent Decree

Pharmaceutical science and technology news.

A ready-to-fill closed vial can improve aseptic filling quality and reduce process complexity.

Pfizer Recalls Lot of Neurontin

Drug Recall

Warning Letter: Compounding at Palace Pharmacy

Pharmaceutical Science and Technology News

The authors argue that chlorine dioxide (CD) is a safe and effective decontaminating agent that can be used for challenging applications.The effectiveness of CD gas for sterilizing complex isolator systems is studied.

FDA Finalizes Guidances on Minimizing Drug Risk and Submitting Pharmacogenomic Data

FDA New Drug Review Times Continue to Drop in 2004

USP to Publish Spanish Translation of USP-NF; Council of Experts Named

Shortages of Key Drugs

Warning Letters: DanChem Technologies & Medsep